belfasttelegraph Wednesday, 1 October, 2014

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated

Search news from around the web

  1. Ligand Pharmaceuticals (NASDAQ:LGND)‘s stock had its “hold” rating reissued by equities researchers at Cantor Fitzgerald in a research report issued on Thursday. They currently have a $49.00 ... FULL ARTICLE AT American Banking News

  2. Research analysts at Cantor Fitzgerald lifted their target price on shares of Ligand Pharmaceuticals (NASDAQ:LGND) from $44.00 to $49.00 in a report released on Wednesday. The firm ... FULL ARTICLE AT American Banking News

  1. Equities research analysts at Craig Hallum set a $90.00 price objective on shares of Ligand Pharmaceuticals (NASDAQ:LGND) stock in a research note issued to investors on Sunday. Craig ... FULL ARTICLE AT American Banking News

  2. Analysts at Brinson Patrick set a $98.00 price target on shares of Ligand Pharmaceuticals (NASDAQ:LGND) stock in a research report issued to clients and investors on Tuesday. Brinson ... FULL ARTICLE AT American Banking News

  3. Analysts at Roth Capital set a $92.00 price target on shares of Ligand Pharmaceuticals (NASDAQ:LGND) stock in a research report issued to clients and investors on Tuesday. The ... FULL ARTICLE AT American Banking News

  1. Research analysts at Griffin Securities set a $95.00 price target on shares of Ligand Pharmaceuticals (NASDAQ:LGND) stock in a report released on Friday. Griffin Securities’ price objective points ... FULL ARTICLE AT American Banking News

  2. Ligand Pharmaceuticals (NASDAQ:LGND) has earned a consensus recommendation of “Hold” from the ten ratings firms that are presently covering the company, Analyst Ratings News reports. One analyst has rated ... FULL ARTICLE AT American Banking News

  3. Ligand Pharmaceuticals Incorporated (LGND) entered into a licensing deal with CURx Pharmaceuticals, under which the former's Captisol-enabled lamotrigine program will be developed and commercialized. FULL ARTICLE AT Zacks Investment Research

  4. Ligand Pharmaceuticals (NASDAQ:LGND) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research note issued on Friday. The firm currently has a $54.00 ... FULL ARTICLE AT American Banking News

About this topic

Wikipedia

Ligand Pharmaceuticals Incorporated (Ligand), incorporated in 1987, is an early-stage biotech company that focuses on discovering and developing new drugs that address medical needs in the areas of thrombocytopenia, cancer, hepatitis C, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand has formed research and development collaborations for its products with numerous... Full Article At Wikipedia.org

Timeline of coverage

  1. Click to see all coverage from 2014-08-17
    2014-08-17
  2. Click to see all coverage from 2014-08-18
    2014-08-18
  3. Click to see all coverage from 2014-08-19
    2014-08-19
  4. Click to see all coverage from 2014-08-20
    2014-08-20
  5. Click to see all coverage from 2014-08-21
    2014-08-21
  6. Click to see all coverage from 2014-08-22
    2014-08-22
  7. Click to see all coverage from 2014-08-23
    2014-08-23
  8. Click to see all coverage from 2014-08-24
    2014-08-24
  9. Click to see all coverage from 2014-08-25
    2014-08-25
  10. Click to see all coverage from 2014-08-26
    2014-08-26
  11. Click to see all coverage from 2014-08-27
    2014-08-27
  12. Click to see all coverage from 2014-08-28
    2014-08-28
  13. Click to see all coverage from 2014-08-29
    2014-08-29
  14. Click to see all coverage from 2014-08-30
    2014-08-30
  15. Click to see all coverage from 2014-08-31
    2014-08-31
  16. Click to see all coverage from 2014-09-01
    2014-09-01
  17. Click to see all coverage from 2014-09-02
    2014-09-02
  18. Click to see all coverage from 2014-09-03
    2014-09-03
  19. Click to see all coverage from 2014-09-04
    2014-09-04
  20. Click to see all coverage from 2014-09-05
    2014-09-05
  21. Click to see all coverage from 2014-09-06
    2014-09-06
  22. Click to see all coverage from 2014-09-07
    2014-09-07
  23. Click to see all coverage from 2014-09-08
    2014-09-08
  24. Click to see all coverage from 2014-09-09
    2014-09-09
  25. Click to see all coverage from 2014-09-10
    2014-09-10
  26. Click to see all coverage from 2014-09-11
    2014-09-11
  27. Click to see all coverage from 2014-09-12
    2014-09-12
  28. Click to see all coverage from 2014-09-13
    2014-09-13
  29. Click to see all coverage from 2014-09-14
    2014-09-14
  30. Click to see all coverage from 2014-09-15
    2014-09-15
  31. Click to see all coverage from 2014-09-16
    2014-09-16
  32. Click to see all coverage from 2014-09-17
    2014-09-17
  33. Click to see all coverage from 2014-09-18
    2014-09-18
  34. Click to see all coverage from 2014-09-19
    2014-09-19
  35. Click to see all coverage from 2014-09-20
    2014-09-20
  36. Click to see all coverage from 2014-09-21
    2014-09-21
  37. Click to see all coverage from 2014-09-22
    2014-09-22
  38. Click to see all coverage from 2014-09-23
    2014-09-23
  39. Click to see all coverage from 2014-09-24
    2014-09-24
  40. Click to see all coverage from 2014-09-25
    2014-09-25
  41. Click to see all coverage from 2014-09-26
    2014-09-26
  42. Click to see all coverage from 2014-09-27
    2014-09-27
  43. Click to see all coverage from 2014-09-28
    2014-09-28
  44. Click to see all coverage from 2014-09-29
    2014-09-29
  45. Click to see all coverage from 2014-09-30
    2014-09-30
  46. Click to see all coverage from 2014-10-01
    2014-10-01

Login

Login to make editorial changes to the current page.

Login Cancel

Close